Editas Medicine (EDIT) Non-Current Debt (2016 - 2025)

Editas Medicine (EDIT) has reported Non-Current Debt for 4 consecutive years, with $53.6 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Non-Current Debt rose 2.23% year-over-year to $53.6 million; the TTM figure through Dec 2025 stood at $53.6 million (up 2.23% YoY), while the FY2025 annual figure was $53.6 million, up 2.23% from the prior year.
• Non-Current Debt eased to $53.6 million in Q4 2025 per EDIT's latest filing, from $54.1 million in the prior quarter.
• Across five years, Non-Current Debt topped out at $54.1 million in Q3 2025 and bottomed at $49.6 million in Q1 2025.